Publications by authors named "Yuka Fujioka"

Article Synopsis
  • * Initial treatment with cyclophosphamide and prednisolone failed and resulted in serious infections, prompting a shift to cord blood transplantation (CBT) after preconditioning.
  • * Post-transplantation, testing showed the disappearance of the STAT3 Y640F variant, indicating that CBT is a promising treatment for refractory T-LGLL and that this genetic marker can help monitor disease activity.
View Article and Find Full Text PDF

A 64-year-old woman presented with agranulocytosis, anemia, and bacteremia, leading to a diagnosis of T-cell large granular lymphocytic leukemia (T-LGLL). A molecular analysis identified a signal transducer and activator of transcription 3 (STAT3) Y640F variant. Initial treatment with cyclophosphamide and prednisolone did not improve her condition, but serious infections were observed.

View Article and Find Full Text PDF

Protein-losing enteropathy is rarely associated with malignant lymphoma. This report describes the case of a 67-year-old man with diffuse large B-cell lymphoma (DLBCL) and concomitant protein-losing enteropathy who was admitted to our hospital for evaluation of watery diarrhea, edema, and abdominal fullness. On admission, the patient reported a history of weight gain.

View Article and Find Full Text PDF

To improve cancer immunotherapy, it is important to understand how tumor cells counteract immune-surveillance. In this study, we sought to identify cell-surface molecules associated with resistance of leukemia cells to cytotoxic T cell (CTL)-mediated cytolysis. To this end, we first established thousands of monoclonal antibodies (mAbs) that react with MLL/AF9 mouse leukemia cells.

View Article and Find Full Text PDF